
Glucoscot MP 1mg/500mg/15mg Tablet SR
Marketer
Ultrascot Biotech Pvt. Ltd.
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glucoscot MP 1mg/500mg/15mg Tablet SR
Diabetol Trio 1mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This regimen, alongside diet and exercise, improves glycemic control in adult type 2 diabetics by enhancing insulin efficiency and reducing blood sugar. Dosage and duration should strictly follow your physician's instructions; take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or skipped meals raises hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions should be disclosed to your doctor before starting treatment, as should pregnancy or breastfeeding. Kidney function will be assessed prior to prescription. Limit alcohol consumption to mitigate potential side effects.
Uses of Glucoscot MP 1mg/500mg/15mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Glucoscot MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glucoscot MP 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Glucoscot MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glucoscot MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glucoscot MP 1mg/500mg/15mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.
How Glucoscot MP 1mg/500mg/15mg Tablet SR works:
Glucoscot MP SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood sugar management when single or dual drug therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, acts through decreased hepatic glucose production, reduced intestinal glucose absorption, and enhanced insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glucoscot MP 1mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glucoscot MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glucoscot MP tablets (1mg/500mg/15mg) are likely unsuitable for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glucoscot MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. This medication is contraindicated for individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Glucoscot MP 1mg/500mg/15mg SR tablets, as dose modification may be necessary. Individuals with severe liver disease should avoid this medication; physician consultation is advised.
What if you forget to take Glucoscot MP 1mg/500mg/15mg Tablet SR :
Should you forget a Glucoscot MP 1mg/500mg/15mg SR Tablet dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glucoscot MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
